Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study

[1]  D. Liebeskind,et al.  Intracranial Atherosclerotic Disease: Mechanisms and Therapeutic Implications , 2019, Stroke.

[2]  K. Furie,et al.  Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm , 2019, Stroke.

[3]  N. Cabral,et al.  Stroke recurrence in the different subtypes of ischemic stroke. The importance of the intracranial disease , 2018, Arquivos de Neuro-Psiquiatria.

[4]  A. Durham,et al.  Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness , 2018, Cardiovascular research.

[5]  F. Kronenberg,et al.  Alpha-1 antitrypsin deficiency: From the lung to the heart? , 2018, Atherosclerosis.

[6]  C. Sudlow,et al.  Common coding variant in SERPINA1 increases the risk for large artery stroke , 2017, Proceedings of the National Academy of Sciences.

[7]  M. Campos,et al.  Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult , 2016 .

[8]  C. Sudlow,et al.  Intracranial Carotid Calcification on Cranial Computed Tomography , 2015, Stroke.

[9]  Qian Xu,et al.  Cytoprotective Role of Alpha-1 Antitrypsin in Vascular Endothelial Cell Under Hypoxia/Reoxygenation Condition , 2015, Journal of cardiovascular pharmacology.

[10]  M. Ehlers.  Immune-modulating effects of alpha-1 antitrypsin , 2014, Biological chemistry.

[11]  L. Duca,et al.  Elastin fragmentation and atherosclerosis progression: the elastokine concept. , 2013, Trends in cardiovascular medicine.

[12]  E. Lewis.  Expanding the Clinical Indications for α1-Antitrypsin Therapy , 2012, Molecular medicine.

[13]  A. von Eckardstein,et al.  Serum levels and genotype distribution of α1-antitrypsin in the general population , 2012, Thorax.

[14]  Jun yan Liu,et al.  Stroke subtype classification: A comparative study of ASCO and modified TOAST , 2012, Journal of the Neurological Sciences.

[15]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Nieminen,et al.  Progression of Atherosclerosis Is Associated With Variation in the &agr;1-Antitrypsin Gene , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  S. Mochizuki,et al.  Signaling Pathways Transduced through the Elastin Receptor Facilitate Proliferation of Arterial Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[18]  K. Angquist,et al.  Serum concentrations of elastin-derived peptides in patients with specific manifestations of atherosclerotic disease. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  J. Moss,et al.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. , 2000, The Journal of biological chemistry.

[20]  B. Mokri,et al.  α1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection , 1994, The Lancet.

[21]  H. Nakamura,et al.  Substratum‐Bound Elastin Pept ide In hi bits Aortic Smooth Muscle Cell Migration in Vitro , 1987, Arteriosclerosis.

[22]  G. Nicoloff,et al.  Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects. , 1987, Atherosclerosis.